Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online February 23, 2007
Diabetes 56:1248-1258, 2007
DOI: 10.2337/db06-1307
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1307v1
56/5/1248    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Attali, M.
Right arrow Articles by Scharfmann, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Attali, M.
Right arrow Articles by Scharfmann, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Control of ß-Cell Differentiation by the Pancreatic Mesenchyme

Myriam Attali1, Volodymyr Stetsyuk1, Annie Basmaciogullari1, Virginie Aiello1, Maria A. Zanta-Boussif2, Bertrand Duvillie1, and Raphael Scharfmann1

1 Faculty of Medicine, University Paris-Descartes, Institut National de la Santé et de la Recherche Médicale, INSERM E363 and U845, Necker Hospital, Paris, France
2 Genethon-Centre National de la Recherche Scientifique Unité Mixte de Recherche 8115, Evry, France

Address correspondence and reprint requests to Raphael Scharfmann, INSERM E363 and U845 Faculté Necker, 156 Rue de Vaugirard, 75015 Paris, France. E-mail: scharfmann{at}necker.fr

Abbreviations: BrdU, bromodeoxyuridine; FGF10, fibroblast growth factor 10; INSERM, Institut National de la Santé et de la Recherche Médicale; PDX1, pancreatic duodenal homeobox-1

The importance of mesenchymal-epithelial interactions for normal development of the pancreas was recognized in the early 1960s, and mesenchymal signals have been shown to control the proliferation of early pancreatic progenitor cells. The mechanisms by which the mesenchyme coordinates cell proliferation and differentiation to produce the normal number of differentiated pancreatic cells are not fully understood. Here, we demonstrate that the mesenchyme positively controls the final number of ß-cells that develop from early pancreatic progenitor cells. In vitro, the number of ß-cells that developed from rat embryonic pancreatic epithelia was larger in cultures with mesenchyme than without mesenchyme. The effect of mesenchyme was not due to an increase in ß-cell proliferation but was due to increased proliferation of early pancreatic duodenal homeobox-1 (PDX1)–positive progenitor cells, as confirmed by bromodeoxyuridine incorporation. Consequently, the window during which early PDX1+ pancreatic progenitor cells differentiated into endocrine progenitor cells expressing Ngn3 was extended. Fibroblast growth factor 10 mimicked mesenchyme effects on proliferation of early PDX1+ progenitor cells and induction of Ngn3 expression. Taken together, our results indicate that expansion of early PDX1+ pancreatic progenitor cells represents a way to increase the final number of ß-cells developing from early embryonic pancreas.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.